MDxHealth (MDXH) Liabilities and Shareholders Equity (2020 - 2026)

MDxHealth (MDXH) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $160.8 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 8.01% year-over-year to $160.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $463.2 million (down 25.34% YoY) and the FY2025 annual result came in at $148.0 million, down 5.96% from the prior year.
• Liabilities and Shareholders Equity improved to $160.8 million in Q1 2026 per MDXH's latest filing, from $148.0 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $174.8 million in Q1 2025, with the low at $162501.0 in Q2 2025.
• Average Liabilities and Shareholders Equity over 5 years is $133.3 million, with a median of $139.1 million recorded in 2023.
• Year-over-year, Liabilities and Shareholders Equity jumped 58.69% in 2022 and slumped 99.88% in 2025.
• MDxHealth's Liabilities and Shareholders Equity stood at $119.1 million in 2022, then climbed by 8.39% to $129.1 million in 2023, then gained by 21.84% to $157.3 million in 2024, then retreated by 5.96% to $148.0 million in 2025, then rose by 8.7% to $160.8 million in 2026.
• Business Quant data shows MDXH's Liabilities and Shareholders Equity at $160.8 million in Q1 2026, $148.0 million in Q4 2025, and $154.3 million in Q3 2025.